Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 265-269

  Downs Jr , Levi S ^a   Chura, Justin C ^a   Argenta, Peter A ^a   Judson, Patricia L ^a   Ghebre, Rahel ^a   Geller, Melissa A ^a   Carson, Linda F ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Carboplatin; Cervical cancer; Ifosfamide; Paclitaxel; Phase II trial

Indexed keywords

ALBUMIN; CARBOPLATIN; CIMETIDINE; CISPLATIN; CREATININE; DEXAMETHASONE; DIPHENHYDRAMINE; ERYTHROPOIETIN; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; ONDANSETRON; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIZATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY CERVIX; HUMAN; INFECTION; LUNG EMBOLISM; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RECURRENT CANCER; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; QUALITY OF LIFE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79251601167     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.020     Document Type: Article

References (20)

1. American Cancer Society Cancer Facts & Figures 2010 Accessed August 17, 2010 via: http://www.cancer.org/acs/groups/content/@nho/documents/document/ acspc-024113.pdf
2. E.L. Franco, N.F. Schlecht, and D. Saslow The epidemiology of cervical cancer Cancer J 9 2003 348 359
3. E. Duarte-Franco, and E.L. Franco Cancer of the uterine cervix BMC Women's Health 4 suppl 1 2004 S13
4. S.E. Waggoner Cervical cancer Lancet 361 2003 2217 2225
5. J.D. Bloss, J.A. Blessing, and B.C. Behrens Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 20 2002 1832 1837
6. H.J. Long, B.N. Bundy, and E.C. Grendys Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study J Clin Oncol 23 2005 4626 4633
7. B.J. Monk, M.W. Sill, and D.S. McMeekin Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 27 2009 4649 4655
8. G. Mountzios, M.A. Dimopoulos, and A. Bamias Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study Ann Oncol 20 2009 1362 1368
9. E.J. Buxton, C.A. Meanwell, and C. Hilton Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer J Natl Cancer Inst 81 1989 359 361
10. G. Zanetta, F. Fei, and G. Parma Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous cell cervical cancer Ann Oncol 10 1999 1171 1174
11. D.M. Shin, B.S. Glisson, and F.R. Khuri Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma J Clin Oncol 16 1998 1325 1330
12. D.M. Shin, F.R. Khuri, and B.S. Glisson Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma Cancer 91 2001 1316 1323
13. L.S. Downs, P.L. Judson, and P.A. Argenta A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer Gynecol Oncol 95 2004 347 351
14. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
15. D.F. Cella, D.S. Tulsky, and G. Gray The functional assessment of cancer therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
16. G.A. Omura, J.A. Blessing, and L. Vaccarello Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 15 1997 165 171
17. J.D. Bloss, J.A. Blessing, and B.C. Behrens Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 20 2002 1832 1837
18. P.G. Rose, J.A. Blessing, D.M. Gershenson, and R. McGehee Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study J Clin Oncol 17 1999 2676
19. D.H. Moore, J.A. Blessing, and R.P. McQuellon Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 22 2004 3113 3119
20. C. Wasserheit, A. Frazein, and R. Oratz Phase II Trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity J Clin Oncol 14 1996 1993 1999